Scientists probe why Anti-B cell therapies fail in kidney rejection

NCT ID NCT07134491

Recruiting now Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Mar 21, 2026 · Last updated Jun 13, 2026 · Updated 15 times

Summary

This study aims to understand why the body sometimes rejects a kidney transplant despite treatment. Researchers will study B cells (a type of immune cell) from 45 adult kidney transplant patients who are having a biopsy or graft removal. By analyzing these cells and their antibodies, they hope to uncover the triggers of rejection and find better ways to prevent graft loss.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Nephrology department, Hôpital Pitié Salpêtière
RECRUITING

Paris, 75013, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Nephrology department, Tenon hospital
NOT_YET_RECRUITING

Paris, 75020, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION